Condition: Central Serous Chorioretinopathy · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone
This description comes directly from the study's public registry record.
Maria Cristina Savastano, MD, PhD · (+39)063015 · mariacristinasavastano@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Agostino Gemelli, IRCCS | Roma, R, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06346405